LION BIOTECHNOLOGIES INC's ticker is LBIO and the CUSIP is 53619R102. A total of 83 filers reported holding LION BIOTECHNOLOGIES INC in Q3 2015. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,164,000 | +1.6% | 505,941 | 0.0% | 0.46% | -21.0% |
| Q2 2016 | $4,098,000 | +61.4% | 505,941 | +1.2% | 0.58% | +52.1% |
| Q1 2016 | $2,539,000 | -34.2% | 499,815 | 0.0% | 0.38% | -17.3% |
| Q4 2015 | $3,859,000 | +34.0% | 499,815 | 0.0% | 0.46% | +0.4% |
| Q3 2015 | $2,879,000 | -37.2% | 499,815 | 0.0% | 0.46% | -24.5% |
| Q2 2015 | $4,583,000 | -10.9% | 499,815 | +17.7% | 0.61% | -23.4% |
| Q1 2015 | $5,145,000 | – | 424,815 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,232,416 | $26,183,000 | 12.58% |
| Avoro Capital Advisors LLC | 4,338,557 | $35,142,000 | 7.81% |
| FRAZIER MANAGEMENT LLC | 774,720 | $6,275,000 | 5.00% |
| Broadfin Capital, LLC | 3,170,759 | $25,683,000 | 2.50% |
| Perceptive Advisors | 3,611,976 | $29,257,000 | 2.03% |
| Ghost Tree Capital, LLC | 700,000 | $5,670,000 | 1.64% |
| Opaleye Management Inc. | 260,000 | $2,106,000 | 1.41% |
| Rhenman & Partners Asset Management AB | 650,000 | $5,265,000 | 0.94% |
| QVT Financial LP | 1,598,309 | $12,946,000 | 0.89% |
| Cormorant Asset Management, LP | 505,941 | $4,098,000 | 0.58% |